Medy-Tox Inc. (KOSDAQ:A086900) announces a share repurchases program. Under the program, the company will repurchase up to 39,777 shares. The purpose of the buyback is to stabilize stock price and increase shareholder value.

The plan will be valid up to September 5, 2022. As of June 6, 2022, the company had 502,654 shares in treasury within scope available for dividend and had 42,413 common stock and 14 other stock in treasury through other repurchase.